Saint Paul, MN, United States of America

Dara Chin

USPTO Granted Patents = 3 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 100(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Dara Chin: Pioneering Innovations in Cardiac Health

Introduction:

In the heart of St. Paul, Minnesota, resides a talented inventor and researcher by the name of Dara Chin. With a strong passion for transforming healthcare through cutting-edge medical devices, Dara has made significant contributions to the field of cardiology. His remarkable patents showcase his commitment to improving lives, particularly in preventing strokes related to the left atrial appendage (LAA). Let's delve into the details of his groundbreaking inventions and learn more about the company he works for, Cardia, Inc.

Patent 1: Left Atrial Appendage Occlusion Device

One of Dara Chin's notable patents is the Left Atrial Appendage occlusion device, a groundbreaking medical implant designed to prevent strokes. The device features a cap that covers the LAA opening, which is connected to a bulb within the LAA. To promote tissue growth over the device, the cap incorporates discontinuous segmented sails. This innovative design ensures the device seamlessly integrates into the patient's heart while effectively reducing the risk of strokes.

Patent 2: Redeployable Left Atrial Appendage Occlusion Device

Dara Chin's quest for improving stroke prevention led to the creation of another remarkable patent: the Redeployable Left Atrial Appendage occlusion device. This medical implant for the LAA offers all the benefits of the previous invention but with the added advantage of repositioning and redeployment during the implantation process. This flexibility enhances the accuracy of the device placement and further optimizes patient outcomes.

Cardia, Inc.: Driving Innovations in Cardiology

Dara Chin's remarkable work has found a home at Cardia, Inc., an esteemed medical device company specializing in cardiology solutions. Cardia, Inc. has a strong reputation for driving innovations in the cardiovascular field, creating state-of-the-art medical devices that address critical needs. With Dara's contributions, Cardia, Inc. continues to pave the way for advancements in cardiac health, offering hope to individuals at risk of stroke and other heart-related conditions.

Colleagues and Collaborators:

Within Cardia, Inc., Dara Chin collaborates with esteemed colleagues who share his passion for improving patient outcomes. Among these individuals, two notable figures stand out: Michael Patrick Corcoran and Gary Erzberger. Together, these brilliant minds work tirelessly to push the boundaries of medical device technology, revolutionizing the field of cardiology.

Conclusion:

Dara Chin's dedication to revolutionizing cardiac health is evident through his innovative patents and contributions within Cardia, Inc. His left atrial appendage occlusion devices demonstrate a deep understanding of the medical field's challenges, highlighting his commitment to preventing strokes and improving patient outcomes. As Dara and his esteemed colleagues continue to push the boundaries of medical device technology, the future looks promising for those at risk of cardiovascular diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…